Eli Lilly and Co
U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the China Development Forum 2026 at the Diaoyutai State Guesthouse on March 22, 2026 in Beijing, China. China News Service | China News Service | Getty Images BEIJING — As corporate giants navigate U.S.-China tensions, more than 80 […]
Read More
Danone to buy protein shake maker Huel as health nutrition craze drives demand shift
Huel makes vegan, powdered meal replacements, catering to people who “deem themselves time-poor” but want healthy, environmentally sustainable meals. Source: Huel French food and beverage maker Danone said Monday it’s set to buy protein drinks maker Huel as a more health-conscious younger generation and the rise of weight-loss drugs pushes companies to rethink what people […]
Read More
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in New York City. Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are now popular for weight loss, according to a […]
Read More
The Dow’s losing streak, fertilizer prices, Novo Nordisk’s new Wegovy shot and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. In a tale of two viral hotspots, Polymarket is planning a pop-up bar in Washington, D.C., while a New York City pharmacy is seeing a surge after its feature in FX’s “Love Story.” Stock futures are down this morning after […]
Read More
Eli Lilly’s new shot shows solid weight loss in study — plus, a way for Nvidia to perk up
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday ‘ s key moments. 1. Stocks fell Thursday as oil prices continued higher. Brent international crude briefly touched $119 per barrel after Iran attacked a key LNG facility in Qatar. Tehran said […]
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from […]
Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight. The drug lowered hemoglobin A1c — a key measure of blood sugar levels — by an average of 1.7% to 2% across different doses at […]
Read More
Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market
HSBC analysts just slashed their recommendation on the world’s most valuable pharmaceutical company, Eli Lilly, signaling a potential cooling period for the red-hot obesity drug trade that has come to dominate market narratives of the sector. Analysts led by Rajesh Kumar downgraded Lilly to Reduce from Hold, cutting their target price to $850 from $1,070, […]
Read More
Stocks making the biggest moves premarket: Nvidia, Delta Air Lines, Eli Lilly & more
Check out the companies making the biggest moves premarket: Nvidia — The chipmaker traded slightly higher after CEO Jensen Huang said he expects orders for its Blackwell and Vera Rubin chips to reach $1 trillion through 2027. Delta Air Lines — Shares traded more than 4% higher after the company raised its first-quarter revenue growth […]
Read More
Stocks making the biggest moves premarket: Bumble, Hims & Hers Health, Blue Owl, Netskope & more
Check out the companies making headlines before the bell. Bumble — Bumble shares popped about 21% after the dating app reported strong adjusted EBITDA and revenue results for its fourth quarter. Its first-quarter adjusted EBITDA guidance also beat analyst consensus expectations, per FactSet. Netskope — Shares of the security and networking company plunged 17% on […]
Read More